Science AdvancesMolecular BiologyPeer-reviewed journal article
Nucleoside Diphosphate Kinases 1 and 2 regulate a protective liver response to a high-fat diet
Domenico IusoiD, I. Garcia-SaeziD, Yohann CoutéiD, Yoshiki Yamaryo‐BottéiD, Elisabetta Boeri ErbaiD, Annie AdraitiD, Nour Zeaiter, Małgorzata Tokarska-SchlattneriD, Zuzana Macek JílkováiD, Fayçal BoussouariD, Sophie BarraliD, Luca SignoriD, Karine CouturieriD, Azadeh HajmirzaiD, Florent ChuffartiD, Ekaterina Bourova-FliniD, Anne-Laure VitteiD, Lisa Bargier, Denis PuthieriD, Thomas DecaensiD, Sophie RousseauxiD, Cyrille Y. BottéiD, Uwe SchlattneriD, Carlo PetosaiD, Saadi KhochbiniD
Abstract
De novo lipogenesis (DNL), the process whereby cells synthesize fatty acids from acetyl-coenzyme A (acetyl-CoA), is deregulated in diverse pathologies, including cancer. Here we report that DNL is negatively regulated by Nucleoside Diphosphate Kinases 1 and 2 (NME1/2), housekeeping enzymes involved in nucleotide homeostasis that were recently discovered to bind co-enzyme A (CoA). We show that NME1 additionally binds acetyl-CoA and that ligand recognition involves a unique binding mode dependent on the CoA/acetyl-CoA 3 phosphate. We report that Nme2 knockout mice fed a high-fat diet (HFD) exhibit excessive triglyceride synthesis and liver steatosis. In liver cells NME2 mediates a gene transcriptional response to HFD leading to DNL repression and activation of a protective gene expression program via targeted histone acetylation. Our findings implicate NME1/2 in the epigenetic regulation of a protective liver response to HFD and suggest a potential role in controlling acetyl-CoA usage between the competing paths of histone acetylation and DNL.
- organism: mouse
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 14
- FWCI
- 1.77
- Field percentile
- top 14%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Paradoxical activation of SREBP1c and de novo lipogenesis by hepatocyte-selective ACLY depletion in obese mice.
Batuhan Yenilmez, Mark Kelly, … Michael Czech·bioRxiv·Mar 21, 2022
- Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
G. Assante, S. Chandrasekaran, … N. A. Youngson·bioRxiv·Jul 22, 2021
- Hepatocyte nuclear factor 4a and glucocorticoid receptor coordinately regulate lipid metabolism in mice fed a high-fat-high-sugar diet
Hong Lü, Xiaohong Lei, … Yazen Alnouti·bioRxiv·Feb 6, 2021
- Autophagy controls lipid droplet formation by fine-tuning NCoR1 levels
M. Komatsu, Y.-S. Sou, … T. Yabe·bioRxiv·Aug 1, 2019
- Constitutive PI3K-AKT activation promotes steatohepatitis through de novo lipogenesis despite enhanced mitochondrial β-oxidation, essential fatty acid depletion and reduced lipid peroxidation
Álbert S. Peixoto, Érique Castro, … William T. Festuccia·bioRxiv·Sep 24, 2026
- Identification and Regulation of a Hepatic Lipogenic Metabolon
Xiaotong Zhu, William Bennion McKean, … Chai-Wan Kim·bioRxiv·Jan 5, 2026